FDA Strengthens Inspections Of Chinese Drug Firms In Heparin Aftermath

BEIJING - As FDA leaders select inspectors to deploy across three offices being set up in China, the agency is also preparing to ramp up the number of inspections and the level of scrutiny of Chinese drug manufacturers that export to the U.S